Latest News

15 October 2018

Draft BASHH gonorrhoea guidelines recommend ciprofloxacin susceptibility testing

Updated Draft BASHH guidelines on the management of gonorrhoea indicate ciprofloxacin as preferential treatment over ceftriaxone if susceptibility is known. ResistancePlus®...

Read More

26 September 2018

SpeeDx Begins Multisite U.S. Clinical Trials of ResistancePlus^® MG

SpeeDx announced the start of patient testing in their multisite U.S.-based clinical trials for ResistancePlus® MG. "This test is an exciting...

Read More

25 July 2018

UK drafts new M. genitalium guidelines: Resistance Guided Therapy to tackle antibiotic resistance

The British Association of Sexual Health and HIV (BASHH) draft guidelines for Mycoplasma genitalium (Mgen) were posted for consultation and...

Read More

16 July 2018

ABC Radio National – Catriona Bradshaw discusses the success of Resistance Guided Therapy for treating M. genitalium

In her interview with Dr Norman Swan on ABC Radio National Health Report, Dr. Bradshaw discusses a new successful treatment...

Read More

12 July 2018

UK BASHH M. genitalium guidelines updated to include macrolide resistance testing

Important updates to the UK BASHH M. genitalium management guidelines are taking the issue of antimicrobial resistance (AMR) seriously. The...

Read More

21 June 2018

Clinical data demonstrates significantly increased cure rates using Resistance Guided Therapy for treating the STI Superbug M. genitalium

SpeeDx ResistancePlus® MG test supports new STI management guidelines SpeeDx Pty. Ltd. today announced clinical data contained in a new study...

Read More